Sana Biotechnology (SANA) analyst forecast and price target
Analyst forecast
Consensus of 10 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| B of A Securities | Maintained | Buy | $6.00 from $7.00 | Aug 14, 2026 |
| Wedbush | Maintained | Outperform | $7.00 from $6.00 | Apr 14, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 from $9.00 | Mar 4, 2026 |
| B of A Securities | Maintained | Buy | $7.00 from $6.00 | Jan 6, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 from $11.00 | Nov 7, 2025 |
| Wedbush | Maintained | Outperform | $6.00 from $5.00 | Nov 7, 2025 |
| Wedbush | Initiated Coverage | Outperform | $5.00 | Sep 24, 2025 |
| Morgan Stanley | Initiated Coverage | Overweight | $12.00 | Jul 3, 2025 |
| JMP Securities | Maintained | Market Outperform | $5.00 | Jun 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Apr 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Mar 18, 2025 |
| Citizens Capital Markets | Upgraded | Market Perform → Market Outperform | $5.00 | Mar 18, 2025 |
| Jefferies | Initiated Coverage | Buy | $7.00 | Mar 14, 2025 |
| TD Cowen | Upgraded | Hold → Buy | — | Jan 8, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 from $8.00 | Jan 8, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Nov 27, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Nov 11, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 from $11.00 | Nov 5, 2024 |
| JMP Securities | Downgraded | Market Outperform → Market Perform | — | Nov 5, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 from $12.00 | Aug 9, 2024 |
Frequently asked questions
Is SANA a buy, sell, or hold?
Analysts covering Sana Biotechnology currently average a Buy rating: 9 buy, 1 hold and 0 sell, from 10 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on SANA?
On Aug 14, 2026, B of A Securities maintained Sana Biotechnology at Buy with a price target of $6.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.